LD-2 disclosure · 2nd Quarter - Report
DENDREON PHARMACEUTICALS, LLC
Expenses$59Kself-filed spend
Client
- Location
- California · United States of America
Registrant
- Description
- biopharmaceutical company that manufactures an immunotherapy for prostate cancer
- Location
- Seal Beach, California, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.
LobbyistsANDREW SAELENS
TargetedSENATE · HOUSE OF REPRESENTATIVES